Mangelsdorf; David J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mangelsdorf; David J..The latest application filed is for "methods and compositions for the treatment of secretory disorders".

Company Profile

1.14.9

Mangelsdorf; David J. - Dallas TX
Mangelsdorf; David J. - San Diego CA
Mangelsdorf; David J. - Duncanville TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions For The Treatment Of Secretory Disorders App 20220257716 - Mangelsdorf; David J. ; et al.	2022-08-18
Use of FGF21 in methods of increasing exocrine pancreatic secretion Grant 11,318,186 - Mangelsdorf , et al. May 3, 2	2022-05-03
Methods And Compositions For The Treatment Of Secretory Disorders App 20190201490 - Mangelsdorf; David J. ; et al.	2019-07-04
Ligands for nematode nuclear receptors and uses thereof Grant 10,117,878 - Mangelsdorf , et al. November 6, 2	2018-11-06
Ligands For Nematode Nuclear Receptors And Uses Thereof App 20130137667 - MANGELSDORF; DAVID J. ; et al.	2013-05-30
Compositions and methods of modulating cholesterol metabolism Grant 8,007,994 - Mangelsdorf , et al. August 30, 2	2011-08-30
Ligands For Nematode Nuclear Receptors And Uses Thereof App 20110028443 - MANGELSDORF; David J. ; et al.	2011-02-03
Ligands for nematode nuclear receptors and uses thereof Grant 7,825,269 - Mangelsdorf , et al. November 2, 2	2010-11-02
Retinoid receptor compositions and methods Grant 7,501,487 - Mangelsdorf , et al. March 10, 2	2009-03-10
Ligands For Nematode Nuclear Receptors And Uses Thereof App 20070219173 - Mangelsdorf; David J. ; et al.	2007-09-20
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor App 20060211768 - Evans; Ronald M. ; et al.	2006-09-21
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor Grant 7,056,954 - Evans , et al. June 6, 2	2006-06-06
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor Grant 6,992,108 - Evans , et al. January 31, 2	2006-01-31
Compositions and methods of modulating cholesterol metabolism App 20050193433 - Mangelsdorf, David J. ; et al.	2005-09-01
Compositions and methods of modulating cholesterol metabolism Grant 6,835,866 - Mangelsdorf , et al. December 28, 2	2004-12-28
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor App 20040006144 - Evans, Ronald M. ; et al.	2004-01-08
Means For The Modulation Of Processes Mediated By Retinoid Receptors And Compounds Useful Therefor App 20030105166 - EVANS, RONALD M. ; et al.	2003-06-05
Selective modulation of processes mediated by retinoid X receptors, and compounds useful therefor Grant 5,990,163 - Evans , et al. November 23, 1	1999-11-23
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor Grant 5,968,989 - Evans , et al. October 19, 1	1999-10-19
Retinoid-inducible response elements Grant 5,747,661 - Evans , et al. May 5, 1	1998-05-05
DNA encoding retinoid receptor X (RXR) alpha and gamma; corresponding vectors and host cells Grant 5,723,329 - Mangelsdorf , et al. March 3, 1	1998-03-03
Orphan steroid hormone receptors Grant 5,696,233 - Evans , et al. December 9, 1	1997-12-09
Receptors Grant 5,571,696 - Evans , et al. November 5, 1	1996-11-05

Company Registrations

NCAGE Code	3QAG6	MANGELSDORF, DAVID J
CAGE Code	3QAG6	MANGELSDORF, DAVID J
S.A.M. Registration	3QAG6 [142493225]	MANGELSDORF, DAVID J

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.